|
JPS60136511A
(ja)
|
1983-12-26 |
1985-07-20 |
Eisai Co Ltd |
高尿酸血症治療剤
|
|
WO1987001938A1
(en)
|
1985-09-27 |
1987-04-09 |
The Regents Of The University Of California |
Liposome transdermal drug delivery system
|
|
JPS6295134A
(ja)
|
1985-10-21 |
1987-05-01 |
Nippon Saafuakutanto Kogyo Kk |
リポソ−ムの製造法
|
|
US5015483A
(en)
|
1989-02-09 |
1991-05-14 |
Nabisco Brands, Inc. |
Liposome composition for the stabilization of oxidizable substances
|
|
US5498607A
(en)
|
1990-07-30 |
1996-03-12 |
University Of Miami |
Treatment for hypercholesterolemia
|
|
JP3765579B2
(ja)
|
1990-08-24 |
2006-04-12 |
イーデーエーアー アーゲー |
作用物質投与用超微小滴状調剤
|
|
US6165500A
(en)
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
|
US5498420A
(en)
|
1991-04-12 |
1996-03-12 |
Merz & Co. Gmbh & Co. |
Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
|
|
EP0648114B1
(de)
|
1992-07-08 |
1997-09-17 |
DIANORM G. Maierhofer GmbH |
Liposomen, verfahren zu ihrer herstellung und ihre verwendung zur herstellung eines arzneimittels
|
|
FR2714382B1
(fr)
|
1993-12-27 |
1996-02-02 |
Roussel Uclaf |
Phospholipides vecteur de molécule active, leur préparation et leur utilisation dans des compositions cosmétiques ou dermatologiques.
|
|
DE4447287C1
(de)
|
1994-12-30 |
1996-11-07 |
Cevc Gregor |
Präparat zum Wirkstofftransport durch Barrieren
|
|
US5902604A
(en)
|
1995-06-06 |
1999-05-11 |
Board Of Regents, The University Of Texas System |
Submicron liposome suspensions obtained from preliposome lyophilizates
|
|
FR2767691B1
(fr)
|
1997-08-27 |
2000-02-18 |
Oreal |
Utilisation d'une dispersion a base de vehicules lipidiques comme composition anti-inflammatoire
|
|
CZ299116B6
(cs)
*
|
1997-11-19 |
2008-04-30 |
Intendis Gmbh |
Prípravek s kyselinou azelainovou
|
|
US6165997A
(en)
|
1997-11-20 |
2000-12-26 |
Statens Serum Institut |
Phospholipids having antimicrobial activity with or without the presence of antimicrobials
|
|
WO2000012060A1
(en)
|
1998-09-01 |
2000-03-09 |
Idea Innovative Dermale Applikationen Gmbh |
Electrically controlled transport of charged penetrants across barriers
|
|
HRP20010309B1
(en)
|
1998-12-23 |
2005-06-30 |
Idea Ag |
Improved formulation for topical non-invasive application in vivo
|
|
PT1031346E
(pt)
|
1999-01-27 |
2002-09-30 |
Idea Ag |
Vacinacao nao invasiva atraves da pele
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
WO2001001962A1
(en)
|
1999-07-05 |
2001-01-11 |
Idea Ag. |
A method for the improvement of transport across adaptable semi-permeable barriers
|
|
US6248728B1
(en)
|
2000-03-10 |
2001-06-19 |
Kansas State University Research Foundation |
Phosphatidylcholine compositions and methods for lowering intestinal absorption and plasma levels of cholesterol
|
|
US6191121B1
(en)
*
|
2000-04-06 |
2001-02-20 |
Nicholas V. Perricone |
Treatment of skin damage using polyenylphosphatidylcholine
|
|
EP1272161B1
(en)
|
2000-04-12 |
2008-01-02 |
Liplasome Pharma A/S |
Lipid-based drug delivery systems against parasitic infections
|
|
TWI281407B
(en)
|
2000-09-18 |
2007-05-21 |
Vasogen Ireland Ltd |
Apoptosis-mimicking synthetic entities and use thereof in medical treatment
|
|
US20030064948A1
(en)
|
2001-02-08 |
2003-04-03 |
Alfred Fahr |
Invasomes for therapy of disorders, their preparation and use
|
|
IL159100A0
(en)
|
2001-05-31 |
2004-05-12 |
Pharmacia Corp |
Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor and a monohydric alcohol
|
|
JP2004535434A
(ja)
|
2001-06-25 |
2004-11-25 |
デピユイ |
関節炎にかかった関節の処置のためのグリコサミノグリカン類のリポソームカプセル化
|
|
CA2368656A1
(en)
|
2002-01-21 |
2003-07-21 |
Vasogen Ireland Limited |
Receptor-ligand pairing for anti-inflammatory response
|
|
US20040009213A1
(en)
|
2002-03-13 |
2004-01-15 |
Thomas Skold |
Water-based delivery systems
|
|
US20040009180A1
(en)
|
2002-07-11 |
2004-01-15 |
Allergan, Inc. |
Transdermal botulinum toxin compositions
|
|
US7473432B2
(en)
|
2002-10-11 |
2009-01-06 |
Idea Ag |
NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
|
|
JP2004131432A
(ja)
|
2002-10-11 |
2004-04-30 |
Kumamoto Technology & Industry Foundation |
悪性腫瘍抑制剤
|
|
MXPA05003744A
(es)
|
2002-10-11 |
2005-09-20 |
Idea Ag |
Agregado de deformabilidad aumentada, que comprende al menos tres anfipatos, para un transporte mejorado a traves de barreras semi-permeables y para la aplicacion de farmacos no invasivos en vivo, en especial a traves de la piel.
|
|
EP1622585A4
(en)
|
2003-05-02 |
2009-07-01 |
Aronex Pharmaceuticals Inc |
LIPID-PLATINUM COMPLEXES AND APPLICATION METHOD THEREFOR
|
|
CA2533084A1
(en)
|
2003-07-21 |
2005-01-27 |
Vasogen Ireland Limited |
Liposomes containing phosphate glycerol groups for treating acute inflammatory condition
|
|
JP2005179313A
(ja)
*
|
2003-12-24 |
2005-07-07 |
Shu Uemura:Kk |
皮膚化粧料用基剤の製造方法および皮膚化粧料
|
|
US7476432B2
(en)
|
2004-05-28 |
2009-01-13 |
Tecton Products |
Phosphorescent pultrusion
|
|
KR20070086045A
(ko)
|
2004-11-12 |
2007-08-27 |
이데아 아게 |
피부 상태 치료에서의 확대된 표면 집합체
|
|
WO2006086992A2
(en)
|
2005-02-18 |
2006-08-24 |
Liplasome Pharma A/S |
Drug delivery systems containing phqspholipase a2 degradable lipid prodrug derivatives and the therapeutic uses thereof as. e.g. wound healing agents and peroxisome proliferator activated receptor ligands
|
|
US20070042008A1
(en)
|
2005-08-18 |
2007-02-22 |
Bodybio, Inc. |
Compositions containing phosphatidylcholine and essential fatty acids
|
|
CA2621066C
(en)
|
2005-08-29 |
2011-11-29 |
Sepsicure L.L.C. |
Method for treatment or prevention of conditions caused by gram-positive bacteria
|
|
US7652068B2
(en)
|
2005-12-20 |
2010-01-26 |
Cenestra Llc |
Omega 3 fatty acid formulations
|
|
JP5009547B2
(ja)
|
2006-03-31 |
2012-08-22 |
株式会社コーセー |
顔料とリポソームを含む化粧料
|
|
US7544375B1
(en)
|
2006-06-12 |
2009-06-09 |
Swiss Skin Repair, Inc. |
Composition
|
|
CA2664944C
(en)
|
2006-09-28 |
2016-06-14 |
Hadasit Medical Research Services & Development Limited |
Use of glycerophospholipids for joint lubrication
|
|
JP4732307B2
(ja)
*
|
2006-11-20 |
2011-07-27 |
株式会社アンズコーポレーション |
ナノエマルション及びそれを配合した化粧料
|
|
US20100130611A1
(en)
|
2006-12-20 |
2010-05-27 |
Cenestra Llc |
Omega 3 fatty acid formulations
|
|
EP1938801A1
(en)
|
2006-12-22 |
2008-07-02 |
Biofrontera Bioscience GmbH |
Nanoemulsion
|
|
US9511016B2
(en)
|
2007-06-12 |
2016-12-06 |
Epicentrx, Inc. |
Topical composition for treating pain
|
|
ITVR20080006A1
(it)
|
2008-01-23 |
2009-07-24 |
David Ceretta |
Apparato per la realizzazione di elementi d'impasto
|
|
ES2335636B1
(es)
|
2008-02-29 |
2011-05-11 |
Lipotec, S.A. |
Composicion cosmetica o dermofarmaceutica de micelas mixtas.
|
|
JP2009256331A
(ja)
|
2008-03-25 |
2009-11-05 |
Nagase Chemtex Corp |
高尿酸血症、又は痛風の予防、改善、又は治療剤
|
|
US20100105139A1
(en)
|
2008-10-27 |
2010-04-29 |
Remco Alexander Spanjaard |
Ligand Targeted Nanocapsules for the delivery of RNAi and other Agents
|
|
CA2751412A1
(en)
|
2009-02-05 |
2010-08-12 |
Targeted Delivery Technologies Limited |
Methods of reducing the proliferation and viability of microbial agents
|
|
EP2437726B1
(en)
|
2009-06-03 |
2018-05-16 |
Sequessome Technology Holdings Limited |
Formulations for the treatment of deep tissue pain
|
|
AU2010283998B2
(en)
|
2009-08-21 |
2015-01-29 |
Targeted Delivery Technologies Limited |
Vesicular formulations
|
|
EP2382994A1
(en)
|
2010-04-26 |
2011-11-02 |
Maurizio Victor Cattaneo |
Ligand targeted nanocapsules for the delivery of RNAi and other agents
|
|
WO2011162802A1
(en)
|
2010-06-21 |
2011-12-29 |
Virun, Inc. |
Compositions containing non-polar compounds
|
|
US20120045405A1
(en)
|
2010-08-18 |
2012-02-23 |
Gilman Miles E |
Under eye cream
|
|
GB201206486D0
(en)
|
2012-04-12 |
2012-05-30 |
Sequessome Technology Holdings Ltd |
Vesicular formulations and uses thereof
|
|
GB201208384D0
(en)
|
2012-05-14 |
2012-06-27 |
Sequessome Technology Holdings Ltd |
Vesicular formulations, uses and methods
|
|
GB201208409D0
(en)
|
2012-05-14 |
2012-06-27 |
Sequessome Technology Holdings Ltd |
Vesicular formulations, kits and uses
|
|
US20160193147A1
(en)
|
2013-07-31 |
2016-07-07 |
Sequessome Technology Holdings Limited |
Vesicles
|